Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug–Drug Interaction Study of Dolutegravir With Once-Weekly Isoniazid and Rifapentine
Clinical infectious diseases/Clinical infectious diseases (Online. University of Chicago. Press)